Chesnara Plc: Fourth acquisition in two years
12 November 2026
Arvinas, Inc. (NASDAQ: ARVN), a biotechnology company based in New Haven, Connecticut, is attracting significant attention from investors looking to capitalize on its innovative approach to..
For investors intrigued by the intersection of biotechnology and mental health, COMPASS Pathways Plc (NASDAQ: CMPS) presents an intriguing opportunity. With a market capitalization of $413.51..
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is navigating the complex biotechnology landscape with a focus on developing innovative therapeutics for retinal diseases. With a market capitalization of..
Investors with an eye on the biopharmaceutical sector might find Akebia Therapeutics, Inc. (NASDAQ: AKBA) a compelling opportunity, especially given its notable potential upside of 131.97%...
Fortrea Holdings Inc. (FTRE), a prominent player in the biotechnology sector, is making waves with its strategic approach to contract research services. Headquartered in Durham, North..
Septerna, Inc. (SEPN), a clinical-stage biotechnology company, is embarking on a promising journey within the healthcare sector, focusing on innovative treatments for various diseases through its..
CureVac N.V. (NASDAQ: CVAC), headquartered in Tübingen, Germany, stands as a notable player in the biotechnology sector, specifically within the realm of healthcare. With a market..
Keros Therapeutics, Inc. (NASDAQ: KROS) stands out in the biotechnology sector with a market capitalization of $616.14 million and a current stock price of $15.17. For..
Amylyx Pharmaceuticals, Inc. (AMLX), a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, is making waves in the biotech industry. Specializing in the discovery and development of..
Zenas BioPharma, Inc. (NASDAQ: ZBIO) is garnering attention in the biotechnology sector with a notable potential upside of 86.48%. This clinical-stage biopharmaceutical company, headquartered in Waltham,..
Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage biotechnology company, is generating considerable investor interest with its focus on precision medicines for targeted oncology and genetic diseases...
Geron Corporation (NASDAQ: GERN), a biopharmaceutical company focused on oncology therapeutics, is currently catching the eye of investors with its remarkable potential upside of 153.5%. Operating..
Gyre Therapeutics, Inc. (NASDAQ: GYRE) is attracting attention in the investment community with its impressive potential upside of 164.90%, according to recent analyst ratings. Operating in..
CareDx, Inc. (NASDAQ: CDNA) is a prominent player in the healthcare sector, specializing in diagnostics and research. With a current market capitalization of approximately $665.87 million,..
Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology firm specializing in innovative oncolytic immunotherapies, stands at a pivotal moment. With a market capitalization of $437.11 million,..
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) is capturing the attention of investors with its strong potential upside of 201.97%, as suggested by analyst ratings. As a..
ArriVent BioPharma, Inc. (NASDAQ: AVBP) is capturing the attention of investors with its intriguing potential in the biotechnology sector, specifically in oncology. As a clinical-stage biopharmaceutical..
Butterfly Network, Inc. (NYSE: BFLY), a pioneering company in the healthcare sector, operates at the forefront of medical device innovation with its ultrasound imaging solutions. Known..
Bicara Therapeutics Inc. (NASDAQ: BCAX) is making waves in the healthcare sector, specifically within the biotechnology industry, with its innovative approach to cancer treatment. Based in..
Valneva SE (VALN), a French biotechnology firm, is carving a niche in the healthcare sector with its focus on developing vaccines for infectious diseases with unmet..
